RESOURCE / PUBLIC SOURCE RECORD
Three years of Team Norway: Health Export
- Upcoming conference listed for 17 November 2026, 14:00–16:30 (GMT+01:00), Oslo, Norway. Registration link is on the page; no fee or specific venue is stated. Page calls it the sixth and final national-team gathering in this format. It says the initiative has delivered tangible international results for Norwegian health companies, reviews results and export development since 2022, collects participating-company feedback and board recommendations, and considers the next phase after 2027. The event description refers to “four years” of collaboration although the title says “Three years.”
- Published programme (GMT+01:00): 14:00 welcome and results, “Three years in — here’s what the team delivered” (Tone Varslot Stave, Innovation Norway, and Eva Camerer, EVP Trade and Invest, Innovation Norway); 14:15–14:45 export development and international drivers, with a Menon Economics report on growth and international factors affecting Norwegian companies (Erik W. Jakobsen, partner/chairman, Menon Economics; Stefan Ohlsson, General Manager, IQVIA Norway); 14:45–14:55 break; 14:55–15:25 “Successes and experiences,” on company experience (Torbjørn Aamodt, CEO Sensio; Cathrine Thomassen, CEO GE Healthcare Norway; Alf-Christian Dybdahl, CEO Laerdal, marked TBC; Øystein Rekdal, CEO Lytix Biopharma); next, a session for national-team input, board recommendations and discussion (Heidi Blengsli Aabel, Vitalthings). The displayed time for this session is “15:25–15:00,” which appears inconsistent with the following 15:45 session. 15:45–16:00: health-export initiative from 2027; 16:00–17:00 mingling. The page says the initiative is part of the government’s “Hele Norge eksporterer” export reform, targeting a 50% increase in non-oil-and-gas exports by 2030.
- Health export team contacts: Tone Varslot Stave, Head of national export initiative on health and life science, Innovation Norway (tone.varslot.stave@innovasjonnorge.no; +47 952 25 533); Heidi Blengsli Aabel, Chief Commercial Officer and Commercial Director at Vitalthings, Trondheim (hbaa@vitalshings.com; +47 411 47 535); Rasmus Malmborg, Investment Manager, Health and life science, Oslo (rasmus.malmborg@innovasjonnorge.no; +47 951 21 480). The page links the health and life-science and radiopharma industry pages. Responsible-business/ESG and due-diligence conditions applied.